Release issued 31st July 2003

York, July 31, 2003 - GlaxoSmithKline plc, the world's second largest pharmaceutical company, has implemented a dynamic campaign to identify potential partners in collaboration with the premier online partnering exchange, Pharmalicensing.

The association with Pharmalicensing is a bold move for a top- three pharmaceutical company, a group of companies that is renowned for its cautious and conservative approach to marketing.

"Although GlaxoSmithKline's contract breaks the mould for a top pharma company, it has joined over 40% of the top-100 companies in this industry which are already using Pharmalicensing as part of a more thorough marketing strategy," commented Samuel Arango, Head of Marketing for the Bridgehead Pharmalicensing Group. "This represents a clear commitment to marketing partnering opportunities online by the pharmaceutical industry, which has been slow in adopting this medium."

"The pharmaceutical industry's slow and more cautious approach has meant that it has been able to learn from other industries' mistakes and access online opportunities at an ideal time, gaining more value for their money," Mr Arango added.

In direct contrast to the struggling marketing industry, companies like Pharmalicensing are making considerable inroads by the use of better targeting and compelling product offerings.

Pharmalicensing Ltd is the leading multi-channel business marketing tool for biopharma companies. In May, Pharmalicensing merged with Bridgehead Technologies Ltd to form the Bridgehead Pharmalicensing Group Ltd., a full service business supplying the needs of companies world wide, ranging from small biotechnology start-ups to leading pharmaceutical and medical companies.

GlaxoSmithKline is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. GlaxoSmithKline's mission is to improve the quality of human life by enabling people to do more, feel better and live longer.

(4th January 2008) UTEK Corporation Acquires Pharmalicensing, Ltd.

(25th July 2007) Pharmalicensing launches 3rd edition of top selling licensing agreement report

(23rd July 2007) Comprehensive consultancy support for your licensing

(15th January 2007) New report from Pharmalicensing highlights the R&D opportunities in China

(1st December 2006) Pharmalicensing's latest report reveals new early stage dealmaking trends